BAM
BLUE

Blueshift Asset Management’s bluebird bio BLUE Stock Holding History

Blueshift Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-555
Closed -$70K – 370
2022
Q3 		$70K Buy
+555
New +$62.8K 0.02% 566
2022
Q1 		– Sell
-1,264
Closed -$253K – 837
2021
Q4 		$253K Buy
+1,264
New +$298K 0.02% 688

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blueshift Asset Management's BLUE Position: Q4 2022 in Review

Blueshift Asset Management sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 555 shares — an estimated $70K sold.

Blueshift Asset Management first reported a position in BLUE in Q4 2021 and held it in 2 quarters. The position peaked at $253K in Q4 2021. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.

  • Blueshift Asset Management reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 555 bluebird bio shares in Q4 2022, an estimated $70K.
  • Blueshift Asset Management first reported a position in bluebird bio in Q4 2021 and held it in 2 quarters.
  • Blueshift Asset Management's bluebird bio position peaked at $253K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.

Based on Blueshift Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.